Gregory R. Beecher - Vice President, Chief Financial Officer and Treasurer
Analyst · Chris Blansett
Thanks Mike, and good morning everyone. Our second quarter sales of $289 million, were up 14% from the prior quarter or diluted earnings per share of $0.14 exceeded our second quarter guidance of $0.08 to $0.13 per share. This bottom-line improvement from our guidance was primarily due to improved Semi Test gross margins. Total bookings of 27 million were up 25% from the prior quarter, led by 28% growth in Semi Test. FLEX bookings set a new record in the quarter with broad customer penetration and wide device coverage, with particular strength in RF, automotive, and power management. Before I go to the second quarter results and provide commentary on the third quarter outlook, I'd like to comment on two things. First, you should be aware that the financial results I'll cover today are expressed excluding our Broadband Test division results, as BTD is treated as a discontinued operation for all periods presented. Second, I'd like to take a step back in putting context where we are against our longer term growth plans. Strategically, first and foremost, we have been focused on building a strong core business in the roughly $3 billion per year system-on-a-chip test sector. This is meant, first, divesting businesses or product lines that are not core or expected to provide attractive returns inside of Teradyne; second, establishing a solid financial model that will deliver improved over-the-cycle profits and strong cash flow; third, fully exploiting our leading SOC test capabilities to gain share with high parallelism and platform extendibility; and lastly, leveraging our financial strength and existing platforms in SOC test to expand into closely adjacent markets. So, where are we in these four strategic initiatives? On the first, we have made good progress in refining the portfolio of businesses that are more closely aligned to our core test capabilities. Most recently, we reached agreement to sell our Broadband Test Business unit to Tollgrade Communications. As we've concluded that that business doesn't offer sufficient growth potential within our array of System Test Businesses. Moving to the second strategic initiative, we have made good progress on our financial discipline. In the last buying cycle that ran from the second quarter of 2005 to the first quarter of 2007, we achieved our highest ever free cash flow which totaled $272 million or 11% of sales over that same period. We expect to improve our profitability and free cash flow performance this next cycle through growing market share and maintaining strong financial discipline. Note that going forward we are reducing our quarterly breakeven range by $10 million to $240 million to $250 million this is at PBIT line and it excludes stock-based compensation ... and it includes stock-based compensation. Roughly half of this improvement is due to the sale of BTD and half is from other cost reductions. Now third, on fully exploiting our leading SOC test capabilities. We have been gaining share with FLEX and J750, and see further opportunities going forward. Our customers are continuing to drive for lower platform diversity, and at the same time they are unrelenting on improving tests economics. We are proving to have a very good value proposition here and are making steady progress steps socket-by-socket. The fourth strategic initiative of expanding into closely adjacent markets is one where we have much work underway but cannot, for obvious reasons, disclose the details. The essence of our strategy is to leverage our engineering investments into Semi Test markets where our base platforms can provide the foundation for a differentiated performance. You have seen the first evidence of this strategy in our J750 EX introduction last quarter into the high performance microcontroller test market. Each of our products, that is, the FLEX and the J750, operate very strong base; both technically and also now in market footprint to effectively execute this fourth component of our strategy. So in summary, our core business is doing well. We expect 2007 to be a share gain year. And we have the strength to make and we are making the longer term investments to get into closely adjacent markets through our existing platforms. So, what does this all mean to our model at this point of time, our average PBIT rate is about 10% or 11%; this includes stock-based comp. This assumes a normal $3 billion annual SOC test market. This is below our annual PBIT model of 15%, therefore we need to gain about 4 points of SOC test share to hit this 15% model. This assumes the normal SOC test profit drop through to about $0.50 to $0.55 on a $1. Although we are only at the halfway mark of 2007, we believe we're on course to add a point or more in SOC test market share this year. Now, apart from growth, we also expect further improvements in manufacturing cost by mid-2008, with the moving of printed circuit board assembly to our outsourced partner's China plant and the outsourcing to that same plant of final configuration and test. In short, we expect this to add about a point of gross margins. Now, let me take you through the details of the second quarter and then our guidance for the third quarter of 2007. Our second quarter, gross margin percentage was 47.5% of sales, up from 44.7% in the prior quarter, due primarily to lower manufacturing costs and higher sales volume. We have described in the past that gross margin should be about 49% at model sales. The second quarter gross margin performance is tracking to our model as for each $25 million of volume up to about $200 million; we expect to get another point of gross margin. R&D expenses were $52.4 million or 18.2% of sales as compared to $49.3 million or 19.4% of sales in the first Quarter. This dollar increase was primarily due to additional engineering to enter a closely adjacent market within existing platform. SG&A expenses were $62.8 million or 21.7% of sales as compared to $63 million or 24.8% of sales in the first quarter. Our net interest income was $9.2 million down from $9.7 million in the prior quarter due primarily to lower average cash balances. We have 3.5 of income-tax expense in the quarter and our quarter ending headcount remained at about 3,700 employees. In the second quarter, semiconductor sales were 79.9% of the total; assembly test; 14.3%, diagnosis solutions 5.8%. On a geographic basis, our second quarter sales in descending percentage order broke down as follows: US, 21%; Taiwan, 19%; Singapore, 15%; Southeast Asia, 15%; Japan, 11%; Europe, 10%; Korea, 7%; and rest of the world, 2%. We have net bookings of $306.6 million in the quarter. On a quarter-to-quarter basis our bookings were up 25%. Semiconductor Test product bookings were up 38%, while Semiconductor Test total bookings were up 28%. Assembly test was up 9% and diagnosis solutions was up 9%. Our book-to-bill ratios for the second quarter were 1.06 for the overall company; 1.12 for Semiconductor Test; 0.84 for assembly test; 0.76 for diagnosis solutions. At the end of the quarter, our backlogs stood at $344 millions of which 85% is scheduled to ship within the next six months. On a geographic basis, our bookings for the quarter, again, descending percentage order, will distribute as follows; Taiwan, 24%; Southeast Asia, 17%; US, 15%; Singapore, 13%; Korea, 13%; Europe, 10%; Japan, 7%; and rest of the world 1%. Moving to the balance sheet, we ended the quarter with cash and marketable securities of $884 million flat with Q1. We used $24 million of cash to repurchase 1.4 million shares at an average price of $16.70. Since the inception of our stock buyback program in the third quarter of 2006, we have repurchased 12.3 million shares at an average price of $13.46 totaling $165 million. This leaves us with a remaining authorization for our share buybacks of $235 million coming into the third quarter. In the second quarter, capital additions net of sales of related capital equipments were $12 million. Depreciation and amortization for the second quarter was $23 million including $6.8 million of stock-based compensation. Accounts receivables stood at $211 million or 67 days sales outstanding up from 60 days in the first quarter. This increase in DSO was due to the timing of shipments occurring later in the quarter. We ended the quarter with product inventory at $88 million, up $7 million from the last quarter. In the third quarter of 2007, as Mike mentioned, we expect sales to be between $300 million and $320 million with income from continuing operations between $0.15 and $0.19. Income from discontinued operations should be about $7 million or $0.04 from the disposition of the Broadband Test Business. We expect gross margins to be 48%, plus or minus, a half a point. R&D should run between 17% and 18%. SG&A should run between 21% and 22%. We expect to be down about $10 million in inventory dollars and accounts receivable to increase about $5 million. In addition we expect to spend $20 million or less on capital. In the third quarter our depreciation and amortization should be around $23 million including $6.8 million of stock-based compensation. Our tax rate is expected to be about 16% for the balance of 2007. Now I'll turn the call back over to Tom.